Why the study?
Does TMVI improve clinical outcomes and eliminate MR in patients ineligible for standard therapy compared to bailout-TEER or medical therapy?
Does TMVI improve clinical outcomes and eliminate MR in patients ineligible for standard therapy compared to bailout-TEER or medical therapy?
TMVI is an effective option for MR patients ineligible for standard therapy, with bailout-TEER serving as a viable alternative for screen failures, whereas medical therapy yields poor outcomes.
Supports TMVI evaluation in ineligible MR patients; leaves open need for randomized comparisons.
In MR patients considered ineligible for standard therapy, TMVI provided acceptable clinical outcomes and MR elimination in the majority of patients. In screen-failed patients, bailout-TEER represented a reasonable alternative while MT was associated with poor outcomes.
No takes yet. Share an insight, caveat, or question.
Ludwig et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: